Robert H Gruninger

Title: The Innovations of Robert H. Gruninger

Introduction

Robert H. Gruninger is a notable inventor based in Easton, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential anti-cancer properties. With a total of 5 patents to his name, Gruninger's work has garnered attention in the scientific community.

Latest Patents

One of Gruninger's latest patents involves the creation of 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives. These compounds, described by the formula (I), include pharmaceutically acceptable salts and processes for their manufacture. The derivatives possess cell cycle inhibitory activity, making them useful in combating cell proliferation, particularly in cancer treatment. This innovative approach highlights Gruninger's commitment to advancing medical science through his inventions.

Career Highlights

Throughout his career, Gruninger has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field.

Collaborations

Gruninger has collaborated with esteemed colleagues such as Ronghui Lin and Peter J. Connolly. These partnerships have played a crucial role in the advancement of his research and the successful development of his patented inventions.

Conclusion

Robert H. Gruninger's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving healthcare. His work continues to inspire future advancements in medical science.